- 期刊
- OpenAccess
Immunomodulation by Decoy Receptor 3: Lessons from Tumors to Therapeutic Approaches
第三誘餌蛋白質之免疫調控：從腫瘤細胞到臨床運用
並列摘要
Decoy receptor 3 (DCR3), also named TR6 or M68, which is a novel member of the tumor necrosis factor receptor (TNFR) superfamily, is currently reported as a deceiver to halt immune attack. Accumulating studies demonstrate that DCR3 may not only ”passively” act as a deceiver, but also ”actively” modulate an immune response that helps tumor cells escape from immune surveillance by interacting with several molecules belonging to the tumor necrosis factor (TNF) superfamily or some unidentified ligands. In this article, we summarize recent findings that describe the therapeutic potential and possible mechanisms of DCR3-mediated immune suppression and further discuss the future prospects as well as some questions that remain unanswered in the therapeutic application of DCR3. Through the understanding of DCR3 and its mechanisms, we may provide a new perspective on the regulation and/or manipulation of the immune response.
延伸閱讀
- Chang, Y. C., & Hsieh, S. L. (2005). 腫瘤壞死因子第三號誘餌受體之免疫調節作用. Formosan Journal of Rheumatology, 19(3&4), 91-96. https://doi.org/10.6313/FJR.2005.19(3-4).02
- 邱宇凡（2013）。分泌型Frizzled相關蛋白1和3對Wnt訊號傳導路徑調控癌細胞的幹細胞特性和腫瘤新生能力中所造成的影響〔碩士論文，國立清華大學〕。華藝線上圖書館。https://doi.org/10.6843/NTHU.2013.00280
- Kao, C. J. (2007). 血球細胞中顆粒性細胞-巨噬細胞聚落刺激因子/第三介白質/第五介白質受體共同乙型鏈結合蛋白(CBAP)鑑別與功能之探討 [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2007.03299
- Chao, Y. H. (2010). 胰島素在Hep3B肝癌細胞中對nocturnin基因表現調節之研究 [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2010.02039
- Ho, Y. H. (2016). E3泛素連接酶ZNRF1在TLR3誘發之免疫反應中的角色 [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201602417